- RLMD Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Relmada Therapeutics (RLMD) 8-K9 Dec 24Relmada Therapeutics to discontinue the Reliance II and Relight Phase 3 studies of REL-1017Financial data
Company Profile